Innovative Approaches for Intestinal Dysbiosis: Integrating Nanotechnology into Pharmacological Interventions-Reference-Cited by-同舟云学术

Innovative Approaches for Intestinal Dysbiosis: Integrating Nanotechnology into Pharmacological Interventions

Published:2023-06 Issue:21 Volume:29 Page:1629-1631
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Giménez Virna Margarita Martín¹^ORCID,Manucha Walter²³^ORCID

Affiliation:

1. Facultad de Ciencias Químicas y Tecnológicas, Instituto de Investigaciones en Ciencias Químicas, Universidad Católica de Cuyo, San Juan 5400, Argentina

2. Área de Farmacología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza 5500, Argentina

3. Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Mendoza 5500, Argentina.

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference15 articles.

1. Belizário J.E.; Faintuch J.; Microbiome and gut dysbiosis. Experientia Suppl 2018,109,459-476

2. Martín Giménez V.M.; Rukavina Mikusic N.L.; Lee H.J.; García Menéndez S.; Choi M.R.; Manucha W.; Physiopathological mechanisms involved in the development of hypertension associated with gut dysbiosis and the effect of nutritional/pharmacological interventions. Biochem Pharmacol 2022,204,115213

3. Robles-Vera I.; de la Visitación N.; Sánchez M.; Mycophenolate improves brain–gut axis inducing remodeling of gut microbiota in DOCA-Salt hypertensive rats. Antioxidants 2020,9(12),1199

4. Santhiravel S.; Bekhit A.E.D.A.; Mendis E.; The impact of plant phytochemicals on the gut microbiota of humans for a balanced life. Int J Mol Sci 2022,23(15),8124

5. Zhang Z.; Zhao J.; Tian C.; Targeting the gut microbiota to investigate the mechanism of lactulose in negating the effects of a high‐salt diet on hypertension. Mol Nutr Food Res 2019,63(11),1800941